Key Findings
The annual cost of MS to Canada is significant, totalling more than $3.4 billion in direct health costs, productivity losses and other costs.
Recent disruptions in Canada’s health care system caused delays in both MS diagnosis and MS treatment, resulting in worse outcomes for Canadians living with MS.
Delayed diagnosis and disrupted treatment generated an additional $578.2 million in MS-related health system expenditure, productivity losses, and lost wellbeing between 2020 and 2024..
These additional health and economic costs will continue into the future, unless we take bold action now…
It’s time to take bold action.
Every day, people living with MS wake up to adversity and do everything in their power to persevere. The uncertain and disruptive times stemming from the pandemic compounded these challenges. MS Canada heard from our community about the challenges to accessing health care and getting a diagnosis – and we’re calling on governments to take bold action to boost care and invest in MS research.
Here’s how you can help.
We are calling on all governments to take bold action now and invest in MS research to prevent MS and improve care by boosting MS specialist care